公司資料
Nemaura Medical 股價、新聞與催化劑
- 股票代碼:
- NMRD
- 交易所:
- PINK
- 產業:
- Biopharma
- 所在地:
- United Kingdom and trades in the U
股票表現
0.00 USD (0.00%)
收盤價
最後更新: 2026年10月1日
—
市值
股價為何變動
截至 2026年10月1日，NMRD 股價變化不大，收於 $0.0001。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Non-Invasive Glucose Monitoring Company
Nemaura Medical develops wearable systems intended to measure glucose without penetrating the skin. Its platform is designed for metabolic health, diabetes management, and behavior-change programs.
SugarBEAT Sensor Platform
SugarBEAT uses a small skin-worn sensor and transmitter to collect glucose readings from interstitial fluid. Data are displayed through a mobile application to show glucose patterns and trends throughout the day.
proBEAT Metabolic Program
proBEAT combines glucose data with coaching and digital tools for people with type 2 diabetes or elevated metabolic risk. The service is intended to help users understand how food, activity, and lifestyle affect glucose response.
Device and Subscription Economics
Potential revenue sources include reusable transmitters, disposable sensors, software, coaching subscriptions, and partnerships with healthcare or wellness organizations. Regulatory clearance and reimbursement are important to broader clinical adoption.
未來催化劑
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。